The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics

Journal of Public Health Management and Practice : JPHMP
Smruti JadavSujit S Sansgiry

Abstract

Considerable disparities in breast cancer screening exist between Hispanic and non-Hispanic white (NHW) women. Identifying and quantifying the factors contributing to these racial-ethnic disparities can help shape interventions and policies aimed at reducing these disparities. This study, for the first time, identified and quantified individual-level sociodemographic and health-related factors that contribute to racial-ethnic disparities in breast cancer screening using the nonlinear Blinder-Oaxaca decomposition method. Analysis of the retrospective pooled cross-sectional Medical Expenditure Panel Survey data from 2000 to 2010 was conducted. Women aged 40 years and older were included in the study. Logistic regressions were used to estimate racial-ethnic disparities in breast cancer screening. Nonlinear Blinder-Oaxaca decomposition method was used to identify and quantify the contribution of each individual-level factor toward racial-ethnic disparities. Based on the unadjusted analyses, Hispanic women had lower odds of receiving mammogram screening (MS) (odds ratio [OR]: 0.74; 95% confidence interval [CI]: 0.69-0.80) and breast cancer screening (OR: 0.75; 95% CI: 0.70-0.81) as compared with NHW women. However, the relationship ...Continue Reading

References

Mar 1, 1995·Journal of Health and Social Behavior·R M Andersen
Nov 22, 2001·Journal of the National Cancer Institute·P S Frame
Dec 19, 2002·Journal of the National Cancer Institute·Robert A HiattRachel Ballard-Barbash
May 21, 2003·The Journal of the American Board of Family Practice·Beverly B Green, Stephen H Taplin
Sep 26, 2003·American Journal of Preventive Medicine·Helen I MeissnerK Robin Yabroff
Oct 11, 2003·Journal of Community Health·Alma R JonesMary Kidd Davis
Apr 19, 2006·Annals of Internal Medicine·Rebecca Smith-BindmanKarla Kerlikowske
Nov 2, 2006·American Journal of Public Health·Paula M LantzSteven J Katz
May 16, 2007·Cancer·Nancy BreenTimothy S McNeel
Jun 17, 2008·Journal of Women's Health·Rebecca PressElsa-Grace V Giardina
Jul 8, 2008·Preventive Medicine·A Blythe RyersonMary C White
Nov 19, 2009·Annals of Internal Medicine·UNKNOWN US Preventive Services Task Force
Nov 16, 2010·Breast Cancer Research and Treatment·Siew Loon OoiChristopher I Li
Feb 8, 2011·Breast Cancer Research and Treatment·Patricia Y MirandaHector M González
Apr 28, 2011·Cancer·Nancy BreenJeannine S Schiller
Aug 16, 2011·Journal of Health Care for the Poor and Underserved·Leiyu ShiJenna Tsai
Dec 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Patricia Y MirandaHector M González
Jan 13, 2012·Joint Commission Journal on Quality and Patient Safety·Sherri O StuverSaul N Weingart
Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·William RakowskiMelissa A Clark
Oct 27, 2012·Breast Cancer Research and Treatment·Erica T WarnerAnn H Partridge
Jan 8, 2013·Frontiers in Oncology·Tainya C ClarkeKristopher L Arheart

❮ Previous
Next ❯

Citations

Jun 13, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Alfredo EcheverriaMichelle Ludwig
Jul 6, 2019·Journal of Community Health·Maria E Rodriguez-AlcaláStephen Jeanetta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.